Please use this identifier to cite or link to this item:
Title: Autophagy induction halts axonal degeneration in a mouse model of x-adrenoleukodystrophy
Author: Launay, Nathalie
Aguado, Carmen
Fourcade, Stéphane
Ruiz, Montserrat
Grau, Laia
Riera, Jordi
Guilera, Cristina
Giròs, Marisa
Ferrer, Isidro (Ferrer Abizanda)
Knecht, Erwin
Pujol Onofre, Aurora
Keywords: Patologia
Issue Date: 1-Mar-2015
Publisher: Springer Verlag
Abstract: X-linked adrenoleukodystrophy (X-ALD) is a rare neurometabolic disease characterized by the accumulation of very long chain fatty acids (VLCFAs) due to a loss of function of the peroxisomal transporter ABCD1. Here, using in vivo and in vitro models, we demonstrate that autophagic flux was impaired due to elevated mammalian target of rapamycin (mTOR) signaling, which contributed to X-ALD pathogenesis. We also show that excess VLCFAs downregulated autophagy in human fibroblasts. Furthermore, mTOR inhibition by a rapamycin derivative (temsirolimus) restored autophagic flux and inhibited the axonal degenerative process as well as the associated locomotor impairment in the Abcd1 (-) /Abcd2 (-/-) mouse model. This process was mediated through the restoration of proteasome function and redox as well as metabolic homeostasis. These findings provide the first evidence that links impaired autophagy to X-ALD, which may yield a therapy based on autophagy activators for adrenomyeloneuropathy patients.
Note: Versió postprint del document publicat a:
It is part of: Acta Neuropathologica, 2015, vol. 129, num. 3, p. 399-415
Related resource:
ISSN: 0001-6322
Appears in Collections:Articles publicats en revistes (Patologia i Terapèutica Experimental)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
Publicacions de projectes de recerca finançats per la UE

Files in This Item:
File Description SizeFormat 
647713.pdf10.89 MBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.